Vol 8, No 4 (2023)
Original article
Published online: 2023-11-14

open access

Page views 368
Article views/downloads 226
Get Citation

Connect on Social Media

Connect on Social Media

Index of cardiometabolic risk based on waist circumference (WHT.5R) and metabolic profile in Polish sedentary male and female students

Marzena Malara1, Patrycja Widłak1, Grażyna Lutosławska1
Medical Research Journal 2023;8(4):300-305.


Introduction: This study aimed to evaluate the potential of WHT.5R to determine metabolic risk in Polish college students of both sexes.

Material and methods: In all volunteers, body weight, body height, and waist circumference were measured and a waist-to-height ratio 0.5 (WHT.5R) was calculated. Of all volunteers, only those with WHT.5R ≤ 0.726 were included in further procedures (132 males, 162 females). Circulating glucose, insulin, triacylglycerol, total cholesterol, and HDL-cholesterol were determined. Plasma concentrations of non-HDL-cholesterol and HOMA-IR were calculated.

Results: In the male group, there was a significantly higher percentage of participants with disturbed lipid profiles, with 20.4% and 28.0% for TC and non-HDL-C, respectively compared to females (13.0% and 9.9%, respectively). No sex-related differences were noted in the percentage of participants with disturbed circulating HDL-C, glucose, and HOMA-IR. Pronounced metabolic disturbances were noted despite WHT.5R values that did not exceed the established cut-off.

Conclusions: In the study population, WHT.5R turned out not to be a reliable index of metabolic disturbances and health risks. However, WHT5.R showed sex-related differences in metabolic profile and confirmed lower metabolic risk in female compared to male students.

Article available in PDF format

View PDF Download PDF file


  1. Adejumo EN, Adejumo AO, Azenabor A, et al. Anthropometric parameter that best predict metabolic syndrome in South west Nigeria. Diabetes Metab Syndr. 2019; 13(1): 48–54.
  2. Bergman RN, Piccinini F, Kabir M, et al. Novel aspects of the role of the liver in carbohydrate metabolism. Metabolism. 2019; 99: 119–125.
  3. Bredella MA. Sex Differences in Body Composition. Adv Exp Med Biol. 2017; 1043: 9–27.
  4. Elagizi A, Kachur S, Carbone S, et al. A review of obesity, physical activity, and cardiovascular disease. Curr Obes Rep. 2020; 9(4): 571–581.
  5. Endukuru CK, Gaur GS, Dhanalakshmi Y, et al. Cut-off values and clinical efficacy of body roundness index and other novel anthropometric indices in identifying metabolic syndrome and its components among Southern-Indian adults. Diabetol Int. 2022; 13(1): 188–200.
  6. Feldman A, Eder SK, Felder TK, et al. Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver. Am J Gastroenterol. 2017; 112(1): 102–110.
  7. Ferrara D, Montecucco F, Dallegri F, et al. Impact of different ectopic fat depots on cardiovascular and metabolic diseases. J Cell Physiol. 2019; 234(12): 21630–21641.
  8. Gažarová M, Galšneiderová M, Mečiarová L. Obesity diagnosis and mortality risk based on a body shape index (ABSI) and other indices and anthropometric parameters in university students. Rocz Panstw Zakl Hig. 2019; 70(3): 267–275.
  9. Godbharle S, Jeyakumar A, Giri BR, et al. Pooled prevalence of food away from home (FAFH) and associated non-communicable disease (NCD) markers: a systematic review and meta-analysis. J Health Popul Nutr. 2022; 41(1): 55.
  10. Hedblad B, Nilsson P, Janzon L, et al. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med. 2000; 17(4): 299–307.
  11. Holmes CJ, Racette SB. The utility of body composition assessment in nutrition and clinical practice: an overview of current methodology. Nutrients. 2021; 13(8).
  12. Jellinger PS, Handelsman Y, Rosenblit PD, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017; 23(Suppl 2): 1–87.
  13. Khan SH, Shahid R, Fazal N, et al. Comparison of various abdominal obesity measures for predicting metabolic syndrome, diabetes, nephropathy, and dyslipidemia. J Coll Physicians Surg Pak. 2019; 29(12): 1159–1164.
  14. Ko SH, Kim HS. Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Nutrients. 2020; 12(1).
  15. Lee JJ, Pedley A, Therkelsen KE, et al. Upper body subcutaneous fat is associated with cardiometabolic risk factors. Am J Med. 2017; 130(8): 958–966.e1.
  16. Lu Y, Liu S, Qiao Y, et al. Waist-to-height ratio, waist circumference, body mass index, waist divided by height and the risk of cardiometabolic multimorbidity: A national longitudinal cohort study. Nutr Metab Cardiovasc Dis. 2021; 31(9): 2644–2651.
  17. Luksiene D, Tamosiunas A, Virviciute D, et al. Anthropometric trends and the risk of cardiovascular disease mortality in a Lithuanian urban population aged 45-64 years. Scand J Public Health. 2015; 43(8): 882–889.
  18. Mansoori A, Hosseini ZS, Ahari RK, et al. Development of data mining algorithms for identifying the best anthropometric predictors for cardiovascular disease: MASHAD cohort study. High Blood Press Cardiovasc Prev. 2023; 30(3): 243–253.
  19. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7): 412–419.
  20. McNeil MA, Merriam S. Menopause. Ann Intern Med. 2021; 174(7): ITC97–ITC112.
  21. Minkin MJ. Menopause: hormones, lifestyle, and optimizing aging. Obstet Gynecol Clin North Am. 2019; 46(3): 501–514.
  22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25): 3143–3421.
  23. Neves JS, Newman C, Bostrom JA, et al. Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes. Diabetes Res Clin Pract. 2022; 190: 109980.
  24. Nevill AM, Duncan MJ, Lahart IM, et al. Scaling waist girth for differences in body size reveals a new improved index associated with cardiometabolic risk. Scand J Med Sci Sports. 2017; 27(11): 1470–1476.
  25. Olatona FA, Onabanjo OO, Ugbaja RN, et al. Dietary habits and metabolic risk factors for non-communicable diseases in a university undergraduate population. J Health Popul Nutr. 2018; 37(1): 21.
  26. Safaei M, Sundararajan EA, Driss M, et al. A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med. 2021; 136: 104754.
  27. Scharnagl H, Nauck M, Wieland H, et al. The Friedewald formula underestimates LDL cholesterol at low concentrations. Clin Chem Lab Med. 2001; 39(5): 426–431.
  28. Schorr M, Dichtel LE, Gerweck AV, et al. Sex differences in body composition and association with cardiometabolic risk. Biol Sex Differ. 2018; 9(1): 28.
  29. Shashaj B, Luciano R, Contoli B, et al. Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol. 2016; 53(2): 251–260.
  30. Simkova SS, Dvorackova O, Velemínsky M. Assessment of healthy lifestyles in relation to BMI. Neuro Endocrinol Lett. 2022; 43(7-8): 393–399.
  31. Szczuko M, Gutowska I, Seidler T. Nutrition and nourishment status of Polish students in comparison with students from other countries. Rocz Panstw Zakl Hig. 2015; 66(3): 261–268.
  32. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. 2006. https://www.idf.org. (13.07.2023).
  33. Tomkin GH, Owens D. Diabetes and dyslipidemia: characterizing lipoprotein metabolism. Diabetes Metab Syndr Obes. 2017; 10: 333–343.
  34. van Deventer HE, Miller WG, Myers GL, et al. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem. 2011; 57(3): 490–501.
  35. van Gent M, Pienaar A, Noorbhai H. Comparison of Body Mass Index and fat percentage criteria classification of 7-13 year-old rural boys in South Africa. BMC Pediatr. 2020; 20(1): 527.
  36. Vilalta A, Gutiérrez JA, Chaves S, et al. Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH. Endocrinol Diabetes Metab. 2022; 5(3): e00335.
  37. Weir CB, Jan A. BMI Classification Percentile And Cut Off Points. StatPearls [Internet], Treasure Island 2023.
  38. Żarnowski A, Jankowski M, Gujski M. Nutrition knowledge, dietary habits, and food labels use-a representative cross-sectional survey among adults in Poland. Int J Environ Res Public Health. 2022; 19(18).